Cairo – Mubasher: Arab Drug Company achieved an 8.5% growth in net profits before tax to EGP 122.2 million during the first 11 months of fiscal year (FY) 2020/2021 from EGP 112.68 million in the same period a year earlier, according to the unaudited income statements.

Net sales also increased to EGP 504.19 million in the period from July 2020 until May 2021, compared to EGP 501.29 million in the corresponding period in the previous FY.

In the first 10 months of the current FY, the company registered net profits before tax worth EGP 113.75 million, compared to EGP 104.73 million in the period from July 2020 until April 2021.

Arab Drug earlier posted a 10.12% annual growth in pre-tax net profits to EGP 103.39 million during the first nine months of FY20/21.